Literature DB >> 20375237

Cyclomodulins in urosepsis strains of Escherichia coli.

Damien Dubois1, Julien Delmas, Anne Cady, Frédéric Robin, Adeline Sivignon, Eric Oswald, Richard Bonnet.   

Abstract

Determinants of urosepsis in Escherichia coli remain incompletely defined. Cyclomodulins (CMs) are a growing functional family of toxins that hijack the eukaryotic cell cycle. Four cyclomodulin types are actually known in E. coli: cytotoxic necrotizing factors (CNFs), cycle-inhibiting factor (Cif), cytolethal distending toxins (CDTs), and the pks-encoded toxin. In the present study, the distribution of CM-encoding genes and the functionality of these toxins were investigated in 197 E. coli strains isolated from patients with community-acquired urosepsis (n = 146) and from uninfected subjects (n = 51). This distribution was analyzed in relation to the phylogenetic background, clinical origin, and antibiotic resistance of the strains. It emerged from this study that strains harboring the pks island and the cnf1 gene (i) were strongly associated with the B2 phylogroup (P, <0.001), (ii) frequently harbored both toxin-encoded genes in phylogroup B2 (33%), and (iii) were predictive of a urosepsis origin (P, <0.001 to 0.005). However, the prevalences of the pks island among phylogroup B2 strains, in contrast to those of the cnf1 gene, were not significantly different between fecal and urosepsis groups, suggesting that the pks island is more important for the colonization process and the cnf1 gene for virulence. pks- or cnf1-harboring strains were significantly associated with susceptibility to antibiotics (amoxicillin, cotrimoxazole, and quinolones [P, <0.001 to 0.043]). Otherwise, only 6% and 1% of all strains harbored the cdtB and cif genes, respectively, with no particular distribution by phylogenetic background, antimicrobial susceptibility, or clinical origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375237      PMCID: PMC2884489          DOI: 10.1128/JCM.02365-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  70 in total

Review 1.  Bacterial toxins that modulate host cell-cycle progression.

Authors:  Eric Oswald; Jean-Philippe Nougayrède; Frédéric Taieb; Motoyuki Sugai
Journal:  Curr Opin Microbiol       Date:  2005-02       Impact factor: 7.934

2.  Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis.

Authors:  James R Johnson; Michael A Kuskowski; Abby Gajewski; Sara Soto; Juan Pablo Horcajada; M Teresa Jimenez de Anta; Jordi Vila
Journal:  J Infect Dis       Date:  2004-11-30       Impact factor: 5.226

3.  Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.

Authors:  Jon M Davis; Humberto M Carvalho; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Gene clusters encoding the cytotoxic necrotizing factor type 1, Prs-fimbriae and alpha-hemolysin form the pathogenicity island II of the uropathogenic Escherichia coli strain J96.

Authors:  G Blum; V Falbo; A Caprioli; J Hacker
Journal:  FEMS Microbiol Lett       Date:  1995-02-15       Impact factor: 2.742

Review 5.  Necrotoxic Escherichia coli (NTEC): two emerging categories of human and animal pathogens.

Authors:  J De Rycke; A Milon; E Oswald
Journal:  Vet Res       Date:  1999 Mar-Jun       Impact factor: 3.683

6.  Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women.

Authors:  James R Johnson; Krista Owens; Abby Gajewski; Michael A Kuskowski
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection.

Authors:  James R Johnson; Flemming Scheutz; Peter Ulleryd; Michael A Kuskowski; Timothy T O'Bryan; Torsten Sandberg
Journal:  Clin Infect Dis       Date:  2005-02-16       Impact factor: 9.079

8.  Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants.

Authors:  Forough L Nowrouzian; Agnes E Wold; Ingegerd Adlerberth
Journal:  J Infect Dis       Date:  2005-03-02       Impact factor: 5.226

9.  Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells.

Authors:  Forough L Nowrouzian; Ingegerd Adlerberth; Agnes E Wold
Journal:  Microbes Infect       Date:  2006-01-13       Impact factor: 2.700

10.  Virulence factors associated with cytotoxic necrotizing factor type two in bovine diarrheic and septicemic strains of Escherichia coli.

Authors:  E Oswald; J de Rycke; P Lintermans; K van Muylem; J Mainil; G Daube; P Pohl
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

View more
  29 in total

Review 1.  Switching Rho GTPase activation into effective antibacterial defenses requires the caspase-1/IL-1beta signaling axis.

Authors:  Laurent Boyer; Emmanuel Lemichez
Journal:  Small GTPases       Date:  2015-10-22

Review 2.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

Review 3.  Prostate cancer and inflammation: the evidence.

Authors:  Karen S Sfanos; Angelo M De Marzo
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

4.  Cytotoxic Escherichia coli strains encoding colibactin colonize laboratory mice.

Authors:  Alexis García; Anthony Mannion; Yan Feng; Carolyn M Madden; Vasudevan Bakthavatchalu; Zeli Shen; Zhongming Ge; James G Fox
Journal:  Microbes Infect       Date:  2016-07-30       Impact factor: 2.700

5.  "Effect of Subinhibitory Concentrations of Some Antibiotics and Low Doses of Gamma Radiation on the Cytotoxicity and Expression of Colibactin by an Uropathogenic Escherichia coli isolate".

Authors:  Radwa N Morgan; Hala A Farrag; Mohammad M Aboulwafa; Sarra E Saleh
Journal:  Curr Microbiol       Date:  2021-01-03       Impact factor: 2.188

Review 6.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides.

Authors:  Damien Dubois; Olivier Baron; Antony Cougnoux; Julien Delmas; Nathalie Pradel; Michèle Boury; Bernadette Bouchon; Marie-Agnès Bringer; Jean-Philippe Nougayrède; Eric Oswald; Richard Bonnet
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

8.  Genotoxic Escherichia coli Strains Encoding Colibactin, Cytolethal Distending Toxin, and Cytotoxic Necrotizing Factor in Laboratory Rats.

Authors:  Susanna A Kurnick; Anthony J Mannion; Yan Feng; Carolyn M Madden; Paul Chamberlain; James G Fox
Journal:  Comp Med       Date:  2019-03-22       Impact factor: 0.982

9.  Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation.

Authors:  Jennifer Raisch; Emmanuel Buc; Mathilde Bonnet; Pierre Sauvanet; Emilie Vazeille; Amélie de Vallée; Pierre Déchelotte; Claude Darcha; Denis Pezet; Richard Bonnet; Marie-Agnès Bringer; Arlette Darfeuille-Michaud
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

10.  Intestinal colonization of genotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor in small mammal pets.

Authors:  Niora J Fabian; Anthony J Mannion; Yan Feng; Carolyn M Madden; James G Fox
Journal:  Vet Microbiol       Date:  2019-11-15       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.